tm logo
LORSIMA
Dead/Cancelled
CANCELLED - SECTION 8

section 8

on 26 Jan 2024

Last Applicant/ Owned by

Industriparken 55

Ballerup

DK

2750

Serial Number

85822215 filed on 14th Jan 2013

Registration Number

5238942 registered on 11th Jul 2017

in the Principal Register

Correspondent Address

SIMOR L. MOSKOWITZ

WESTERMAN HATTORI DANIELS & ADRIAN LLP

1250 CONNECTICUT AVENUE, NW

SUITE 700

WASHINGTON, DC 20036

Filing Basis

1. intent to use

Disclaimer

NO DATA

LORSIMA

Pharmaceutical preparations for the treatment of cancer and dermatological, hematological, renal and endocrine disorders excluding those specifically for the treatment of acne and for hormone related diseases; powders, talcum powders, creams, lotions, gels, foundation and lip balm for the treatment of dermatological disorders, cancer and skin infections; medicated shampoos

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of cancer and dermatological, hematological, renal and endocrine disorders excluding those specifically for the treatment of acne and for hormone related diseases; powders, talcum powders, creams, lotions, gels, foundation and lip balm for the treatment of dermatological disorders, cancer and skin infections; medicated shampoos

Mark Details


Serial Number

No 85822215

Mark Type

No Service/Collective Mark

Attorney Docket Number

No TM11947US02

44D Filed

No

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
26th Jan 2024CANCELLED SEC. 8 (6-YR)
11th Jul 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11th Jul 2017REGISTERED-PRINCIPAL REGISTER
25th Apr 2017PUBLISHED FOR OPPOSITION
25th Apr 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05th Apr 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17th Mar 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
15th Mar 2017APPROVED FOR PUB - PRINCIPAL REGISTER
14th Mar 2017TEAS/EMAIL CORRESPONDENCE ENTERED
13th Mar 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED